申请人:Pfizer Inc
公开号:US20040122038A1
公开(公告)日:2004-06-24
The present invention provides NPY-5 receptor antagonists having a Formula (I)
1
Methods and pharmaceutical compositions useful for treating diseases, conditions and/or disorders modulated by the above NPY-5 receptor antagonists are also provided.
本发明提供了具有式(I)的NPY-5受体拮抗剂,同时还提供了用于治疗由上述NPY-5受体拮抗剂调节的疾病、症状和/或疾患的方法和药物组合物。